Business
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening
REHOVOT, Israel, April 25, 2022 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"REHOVOT, Israel, April 25, 2022 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that CEO Yehiel Tal will moderate the International Society for Biofabrication's (ISBF) virtual event on May 2nd. Mr. Tal also serves as a board member of ISBF.\n\n \n \n \n \n \n \n\n \nThe event will be hosted by the ISBF's Industry Relations Committee and feature experts in the field from academia and industry: Dr. Daniel Levner, co-founder and CTO of Emulate, Dr. Ben Maoz from Tel Aviv University, Dr. Lutz Kloke, founder and CSO of Cellbricks and Dr. Jeroen Eyckmans from Boston University. The Q&A session will be moderated by Ms. Katie Weimer, VP Regenerative Medicine at 3D systems and a member of the ISBF's Industry Relations Committee.\nEvent title: Biofabrication of Microphysiological Systems for Drug Discovery and Screening - Future OutlookDate: Monday, May 2, 2022Time: 10:00 AM EST / 4:00 PM CET / 11:00 PM JSTLocation: Virtual eventRegistration link\nThe Industry Relations Committee of ISBF is serving as a mediator of academia-industry and industry-industry to promote and stimulate collaboration; developing mechanisms to facilitate translation of laboratory discoveries into manufactured products; and representing the industry in all Biofabrication aspects including roadmap, technologies, cell biology, large scale manufacturing, regulation, and commercialization.\nFor more details and to register, please visit https://biofabricationsociety.org/ \nAbout the International Society for Biofabrication\nFrom basic science to medical applications, the biofabrication community convened at the International Conference on Biofabrication (Biofabrication 2019). The field of biofabrication is dedicated to researching and integrating technologies such as bio-printing, bio-plotting, and bio-assembly into applications such as engineered tissue systems and regenerative medicine. The International Society for Biofabrication's (ISBF) core purpose is to foster scientific and technological innovation and excellence for the benefit of humanity. ISBF promotes the interaction between and convergence in the different disciplines of the field of Biofabrication, as well as between basic research and applied practice. ...